Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario
dc.contributor.author | Kessler, Ronald C. | en_US |
dc.contributor.author | Berglund, Patricia A. | en_US |
dc.contributor.author | Dewit, David J. | en_US |
dc.contributor.author | Bedirhan Üstün, T. | en_US |
dc.contributor.author | Wang, Philip S. | en_US |
dc.contributor.author | Wïttchen, Hans-Ulrich | en_US |
dc.date.accessioned | 2006-04-18T20:52:31Z | |
dc.date.available | 2006-04-18T20:52:31Z | |
dc.date.issued | 2002-08 | en_US |
dc.identifier.citation | Kessler, Ronald C.; Berglund, Patricia A.; Dewit, David J.; Bedirhan ÜstÜn, T.; Wang, Philip S.; WÏttchen, Hans-Ulrich (2002)."Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario." International Journal of Methods in Psychiatric Research 11(3): 99-111. <http://hdl.handle.net/2027.42/34220> | en_US |
dc.identifier.issn | 1049-8931 | en_US |
dc.identifier.issn | 1234-988X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/34220 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12459823&dopt=citation | en_US |
dc.description.abstract | Estimation of comparative disease burden in epidemiological surveys is complicated by the fact that high comorbidities exist among many chronic conditions. The easiest way to take comorbidity into consideration is to distinguish between pure and comorbid conditions and to evaluate the incremental effects of comorbid conditions in prediction equations. This approach is illustrated here in an analysis of the effects of pure and comorbid major depression (MD) and generalized anxiety disorder (GAD) on a number of different measures of role impairment in the US National Comorbidity Survey (NCS) and the Mental Health Supplement to the Ontario (Canada) Health Survey (the Supplement). Pure MD and pure GAD were found to have roughly equal independent associations with role impairments. The incremental effects of having comorbid MD and GAD were found to vary depending on the outcome under investigation. The paper closes with a discussion of the methodological complexities associated with generalizing to comorbidities that involve rare conditions or more than two disorders. Copyright © 2002 Whurr Publishers Ltd. | en_US |
dc.format.extent | 97210 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | John Wiley & Sons, Ltd. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.title | Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Institute for Social Research, University of Michigan, Ann Arbor MI, USA | en_US |
dc.contributor.affiliationother | Department of Health Care Policy, Harvard Medical School, Boston MA, USA ; Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115. | en_US |
dc.contributor.affiliationother | Social, Prevention and Health Policy Research Department, Centre for Addiction and Mental Health, London, Ontario, Canada, and Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada | en_US |
dc.contributor.affiliationother | Assessment, Classification and Epidemiology Group, World Health Organization, Geneva, Switzerland | en_US |
dc.contributor.affiliationother | Department of Health Care Policy, Harvard Medical School, Boston MA, and Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital Boston MA, USA | en_US |
dc.contributor.affiliationother | Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, and Max Planck Institute of Psychiatry, Munich, Germany | en_US |
dc.identifier.pmid | 12459823 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/34220/1/128_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/mpr.128 | en_US |
dc.identifier.source | International Journal of Methods in Psychiatric Research | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.